Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in by Nowak, Anna K, Prof, Lesterhuis, W Joost, PhD, Kok, Peey-Sei, MBBCh, Brown, Chris, MBiostat, Hughes, Brett GM, MBBS, Karikios, Deme J, PhD, John, Thomas, PhD, Kao, Steven C-H, PhD, Leslie, Connull, MBBS, Cook, Alistair M, PhD, Pavlakis, Nick, MBBS, Briscoe, Karen, MBBS, O'Byrne, Kenneth J, Prof, Karapetis, Christos S, Prof, Lam, Wei-Sen, MBBS, Langford, Ailsa, BSc, Yip, Sonia, PhD, Stockler, Martin R, MBBS

Get full text